A files 8-K — Item 7.01 Regulation FD

# Agilent Technologies 8-K Filing Note

What Was Filed

Agilent Technologies, Inc. filed an 8-K with the SEC (EDGAR accession number 000119312526202636) on May 4, 2026 at 08:05:15, disclosing Items 5.02 and 7.01, with Item 7.01 (Regulation FD) as the lead disclosure. Per SEC plain-language rules, Item 7.01 covers material non-public information not previously disclosed to avoid selective disclosure, while Item 5.02 addresses changes in principal officers or directors. The filing aligns with the May 4 Business Wire headline announcing Michael Buckner as the company’s new Chief Legal Officer.

The Disclosure

The dual-item filing ties a leadership appointment (Item 5.02) to accompanying material operational or financial updates (Item 7.01). For a $32.4B market cap healthcare diagnostics firm, Item 7.01 is highly likely to include forward-looking financial guidance, a major contract win, or updated market outlook ahead of Agilent’s May 27, 2026 quarterly earnings report. The lead designation of Item 7.01 prioritizes the non-public operational or financial update over the leadership change disclosure.

Cross-Reference to Prior Signals

The most recent insider activity prior to this filing was an April 2, 2026 in-kind share transfer of 153 Agilent shares by Senior Vice President Meghan Henson, valued at $17,439, with no open market sales reported in the prior 90 days. Analyst rating distribution shifted slightly between March 1 and April 1, 2026: Strong Buy holdings held steady at 4, Buy ratings fell from 11 to 10, and Hold ratings fell from 6 to 5, with no Sell or Strong Sell ratings issued in either period. The December 31, 2025 13F filing shows 1,171 institutional holders owning 90.6% of Agilent’s float, with total institutional assets under management of $59.0B. The most recent quarterly earnings report prior to this filing was February 25, 2026, where Agilent posted inline EPS of $1.36 vs. consensus estimates of $1.37, and a slight revenue miss of $1.798B vs. estimates of $1.808B.

What This Filing Does NOT Tell Us

1) The full text of the Item 7.01 Regulation FD disclosure, including specific forward-looking financial metrics or contract details that would impact near-term performance.

2) The exact compensation package, severance terms, or employment duration for newly appointed Chief Legal Officer Michael Buckner, which are required under Item 5.02 but not included in the high-level 8-K filing.

3) Whether the April 28 and 29, 2026 SC 13G institutional filings represent position changes tied to the disclosed leadership appointment or operational updates.